641639-55-6 Usage
General Description
Methyl 5-(4-methylsulfanyl-phenyl)-1-(4-trifluoromethyl-phenyl)-1H-pyrazole-3-carboxylate is a complex organic compound with a molecular structure that contains a pyrazole ring and carboxylate group. It is a derivative of pyrazole and exhibits potential pharmacological activity. The presence of the trifluoromethyl group and the methylsulfanyl group in the chemical structure indicates its potential in medicinal chemistry as well as in agrochemical applications. METHYL 5-(4-METHYLSULFANYL-PHENYL)-1-(4-TRIFLUOROMETHYL-PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE may have the potential for use in pharmaceuticals and agrochemicals due to its unique molecular structure and potential biological activities. Further research and testing may reveal its specific applications and potential benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 641639-55-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,1,6,3 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 641639-55:
(8*6)+(7*4)+(6*1)+(5*6)+(4*3)+(3*9)+(2*5)+(1*5)=166
166 % 10 = 6
So 641639-55-6 is a valid CAS Registry Number.
InChI:InChI=1/C19H15F3N2O2S/c1-26-18(25)16-11-17(12-3-9-15(27-2)10-4-12)24(23-16)14-7-5-13(6-8-14)19(20,21)22/h3-11H,1-2H3
641639-55-6Relevant articles and documents
Synthesis and Selective Cyclooxygenase-2 Inhibitory Activity of a Series of Novel, Nitric Oxide Donor-Containing Pyrazoles
Ranatunge, Ramani R.,Augustyniak, Michael,Bandarage, Upul K.,Earl, Richard A.,Ellis, James L.,Garvey, David S.,Janero, David R.,Letts, L. Gordon,Martino, Allison M.,Murty, Madhavi G.,Richardson, Stewart K.,Schroeder, Joseph D.,Shumway, Matthew J.,Tam, S. William,Trocha, A. Mark,Young, Delano V.
, p. 2180 - 2193 (2007/10/03)
The synthesis of a series of novel pyrazoles containing a nitrate (ONO 2) moiety as a nitric oxide (NO)-donor functionality is reported. Their COX-1 and COX-2 inhibitory activities in human whole blood are profiled. Our data demonstrate that py
